Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01959958 · ClinicalTrials.gov registry record

Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
250
Enrollment target

NCT01959958: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT01959958 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01959958 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
250 participants
Enrollment target

Study Summary

Pediatric patients with sickle cell disease are at greater risk for exhibiting nocturnal enuresis (bedwetting) compared to the general population. This increased risk has been attributed to a decreased ability to concentrate urine caused by sickling-induced nephropathy. The sociodemographic, psychosocial, and medical factors associated with nocturnal enuresis are not well defined. In addition, the impact of these behaviors on emotional and behavioral functioning, along with health-related quality of life are not clear. Despite the availability of evidence-based interventions for nocturnal enuresis, very few families with a child with sickle cell disease have utilized these methods. The reasons for this underutilization of interventions are not clear.

Primary Outcome

Health-related quality of life, emotional and behavioral functioning, family functioning, stressful life events, sociodemographic factors and medical factors will be examined from questionnaire responses. Classification will be based on the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Data will be stratified by age (6-11 years and 12-18 years) and genotype (HbSS/ HbSβ0 thalassemia and HbSC/ HbSβ+ thalassemia). The sample

Interventions

  • OTHER Questionnaire/Interview

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2013-10
Est. Completion 2016-04

What the finished NCT01959958 record still lists

NCT01959958 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Questionnaire/Interview is the first listed.

NCT01959958 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01959958 about?

NCT01959958 is a clinical study titled "Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease". Pediatric patients with sickle cell disease are at greater risk for exhibiting nocturnal enuresis (bedwetting) compared to the general population. This increased risk has been attributed to a decreased ability to concentrate urine caused by sickling-induced nephropathy. The sociodemographic, psychos...

What is the current status of trial NCT01959958?

This trial is currently completed. The enrollment target is 250 participants. The study started on 2013-10. Estimated completion is 2016-04.

What interventions are being tested in trial NCT01959958?

The interventions under investigation include: Questionnaire/Interview (OTHER).

Who is sponsoring clinical trial NCT01959958?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01959958, the US trial registry maintained by the National Library of Medicine. NCT01959958 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.